{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T19:49:50Z","timestamp":1790538590572,"version":"4.1.0"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,5,12]],"date-time":"2017-05-12T00:00:00Z","timestamp":1494547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,5,12]],"date-time":"2017-05-12T00:00:00Z","timestamp":1494547200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>We previously reported that activation of the host autophagic protein, Beclin1, by HIV-1 infection represents an essential mechanism in controlling HIV replication and viral-induced inflammatory responses in microglial cells. Existing antiretroviral therapeutic approaches have been limited in their ability to cross the blood-brain barrier effectively and recognize and selectively eliminate persistent HIV-infected brain reservoirs. In the present study and for the first time, the bio-distribution and efficacy of noninvasive intranasal delivery of small interfering\u00a0RNA (siRNA) against the Beclin1 gene using the cationic linear polyethylenimines (PEI) as a gene carrier was investigated in adult mouse brain. Fluorescein isothiocyanate (FITC)-labeled control siRNA delivered intranasally was found in the cytoplasm of neurons and glial cells of the prefrontal cortex at 4 and 24\u2009hours post-delivery, with no major adverse immune reaction encountered. Intranasal delivery of the siRNA targeting Beclin1 significantly depleted the target protein expression levels in brain tissues with no evidence of toxicity. Binding of siRNA to PEI-polymer was characterized and confirmed by Raman spectroscopy. These results indicate that the intranasal drug delivery allows for the direct delivery of the PEI-siRNA nano-complex to the central nervous system, which could potentially offer an efficient means of gene silencing-mediated therapy in the HIV-infected brain.<\/jats:p>","DOI":"10.1038\/s41598-017-01819-9","type":"journal-article","created":{"date-parts":[[2017,5,8]],"date-time":"2017-05-08T11:43:07Z","timestamp":1494243787000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":97,"title":["Intranasal drug delivery of small interfering RNA targeting Beclin1 encapsulated with polyethylenimine (PEI) in mouse brain to achieve HIV attenuation"],"prefix":"10.1038","volume":"7","author":[{"given":"Myosotys","family":"Rodriguez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Lapierre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chet Raj","family":"Ojha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajeet","family":"Kaushik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Batrakova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatah","family":"Kashanchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seth M.","family":"Dever","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhavan","family":"Nair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazira","family":"El-Hage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,5,12]]},"reference":[{"key":"1819_CR1","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s13365-014-0291-1","volume":"21","author":"A Nath","year":"2015","unstructured":"Nath, A. Eradication of human immunodeficiency virus from brain reservoirs. Journal of neurovirology 21, 227\u2013234 (2015).","journal-title":"Journal of neurovirology"},{"key":"1819_CR2","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1038\/35073667","volume":"410","author":"M Kaul","year":"2001","unstructured":"Kaul, M., Garden, G. A. & Lipton, S. A. Pathways to neuronal injury and apoptosis in HIV-associated dementia. Nature 410, 988\u2013994 (2001).","journal-title":"Nature"},{"key":"1819_CR3","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1080\/13550280600827369","volume":"12","author":"MJ Churchill","year":"2006","unstructured":"Churchill, M. J. et al. Transcriptional activity of blood-and cerebrospinal fluid-derived nef\/long-terminal repeat sequences isolated from a slow progressor infected with nef-deleted human immunodeficiency virus type 1 (HIV-1) who developed HIV-associated dementia. Journal of neurovirology 12, 219\u2013228 (2006).","journal-title":"Journal of neurovirology"},{"key":"1819_CR4","doi-asserted-by":"publisher","first-page":"230","DOI":"10.3109\/13550281003735709","volume":"16","author":"SL Lamers","year":"2010","unstructured":"Lamers, S. L. et al. Human immunodeficiency virus-1 evolutionary patterns associated with pathogenic processes in the brain. Journal of neurovirology 16, 230\u2013241 (2010).","journal-title":"Journal of neurovirology"},{"key":"1819_CR5","first-page":"432","volume":"4","author":"L Ene","year":"2011","unstructured":"Ene, L., Duiculescu, D. & Ruta, S. M. How much do antiretroviral drugs penetrate into the central nervous system? Journal of medicine and life 4, 432\u2013439 (2011).","journal-title":"Journal of medicine and life"},{"key":"1819_CR6","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/sj.gt.3302356","volume":"12","author":"RC Ryther","year":"2005","unstructured":"Ryther, R. C., Flynt, A. S., Phillips, J. A. 3rd & Patton, J. G. siRNA therapeutics: big potential from small RNAs. Gene therapy 12, 5\u201311 (2005).","journal-title":"Gene therapy"},{"key":"1819_CR7","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.drudis.2006.10.013","volume":"12","author":"WM Pardridge","year":"2007","unstructured":"Pardridge, W. M. Blood-brain barrier delivery. Drug discovery today 12, 54\u201361 (2007).","journal-title":"Drug discovery today"},{"key":"1819_CR8","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.addr.2007.03.008","volume":"59","author":"WM Pardridge","year":"2007","unstructured":"Pardridge, W. M. shRNA and siRNA delivery to the brain. Advanced drug delivery reviews 59, 141\u2013152 (2007).","journal-title":"Advanced drug delivery reviews"},{"key":"1819_CR9","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.addr.2016.06.011","volume":"104","author":"HJ Kim","year":"2016","unstructured":"Kim, H. J., Kim, A., Miyata, K. & Kataoka, K. Recent progress in development of siRNA delivery vehicles for cancer therapy. Advanced drug delivery reviews 104, 61\u201377 (2016).","journal-title":"Advanced drug delivery reviews"},{"key":"1819_CR10","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1038\/mt.2009.36","volume":"17","author":"A Akinc","year":"2009","unstructured":"Akinc, A. et al. Development of lipidoid-siRNA formulations for systemic delivery to the liver. Molecular therapy: the journal of the American Society of Gene Therapy 17, 872\u2013879 (2009).","journal-title":"Molecular therapy: the journal of the American Society of Gene Therapy"},{"key":"1819_CR11","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/j.addr.2009.03.003","volume":"61","author":"YC Tseng","year":"2009","unstructured":"Tseng, Y. C., Mozumdar, S. & Huang, L. Lipid-based systemic delivery of siRNA. Advanced drug delivery reviews 61, 721\u2013731 (2009).","journal-title":"Advanced drug delivery reviews"},{"key":"1819_CR12","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1021\/bm8009973","volume":"10","author":"ML Patil","year":"2009","unstructured":"Patil, M. L. et al. Internally cationic polyamidoamine PAMAM-OH dendrimers for siRNA delivery: effect of the degree of quaternization and cancer targeting. Biomacromolecules 10, 258\u2013266 (2009).","journal-title":"Biomacromolecules"},{"key":"1819_CR13","doi-asserted-by":"crossref","unstructured":"Zhou, J. et al. PAMAM dendrimers for efficient siRNA delivery and potent gene silencing. Chemical communications (Cambridge, England), 2362\u20132364 (2006).","DOI":"10.1039\/b601381c"},{"key":"1819_CR14","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.jconrel.2006.01.022","volume":"112","author":"C Zhang","year":"2006","unstructured":"Zhang, C. et al. siRNA-containing liposomes modified with polyarginine effectively silence the targeted gene. Journal of controlled release 112, 229\u2013239 (2006).","journal-title":"Journal of controlled release"},{"key":"1819_CR15","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1021\/nl9003865","volume":"9","author":"A Elbakry","year":"2009","unstructured":"Elbakry, A. et al. Layer-by-layer assembled gold nanoparticles for siRNA delivery. Nano letters 9, 2059\u20132064 (2009).","journal-title":"Nano letters"},{"key":"1819_CR16","first-page":"1","volume":"10","author":"M Rodriguez","year":"2016","unstructured":"Rodriguez, M. et al. Electro-Magnetic Nano-Particle Bound Beclin1 siRNA Crosses the Blood-Brain Barrier to Attenuate the Inflammatory Effects of HIV-1 Infection in Vitro. Journal of neuroimmune pharmacology 10, 1\u201313 (2016).","journal-title":"Journal of neuroimmune pharmacology"},{"key":"1819_CR17","doi-asserted-by":"publisher","first-page":"7297","DOI":"10.1073\/pnas.92.16.7297","volume":"92","author":"O Boussif","year":"1995","unstructured":"Boussif, O. et al. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proceedings of the National Academy of Sciences of the United States of America 92, 7297\u20137301 (1995).","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"1819_CR18","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/sj.gt.3302425","volume":"12","author":"B Urban-Klein","year":"2005","unstructured":"Urban-Klein, B., Werth, S., Abuharbeid, S., Czubayko, F. & Aigner, A. RNAi-mediated gene-targeting through systemic application of polyethylenimine (PEI)-complexed siRNA in vivo. Gene therapy 12, 461\u2013466 (2005).","journal-title":"Gene therapy"},{"key":"1819_CR19","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/978-1-4939-3718-9_12","volume":"1445","author":"A Ewe","year":"2016","unstructured":"Ewe, A. & Aigner, A. Cationic Lipid-Coated Polyplexes (Lipopolyplexes) for DNA and Small RNA Delivery. Methods in molecular biology (Clifton, N. J.) 1445, 187\u2013200 (2016).","journal-title":"Methods in molecular biology (Clifton, N. J.)"},{"key":"1819_CR20","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1745-6673-2-16","volume":"2","author":"SS Suri","year":"2007","unstructured":"Suri, S. S., Fenniri, H. & Singh, B. Nanotechnology-based drug delivery systems. Journal of occupational medicine and toxicology (London, England) 2, 16 (2007).","journal-title":"Journal of occupational medicine and toxicology (London, England)"},{"key":"1819_CR21","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1002\/jps.21924","volume":"99","author":"SV Dhuria","year":"2010","unstructured":"Dhuria, S. V., Hanson, L. R. & Frey, W. H. 2nd Intranasal delivery to the central nervous system: mechanisms and experimental considerations. Journal of pharmaceutical sciences 99, 1654\u20131673 (2010).","journal-title":"Journal of pharmaceutical sciences"},{"key":"1819_CR22","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1089\/hum.2008.023","volume":"19","author":"SM Buckley","year":"2008","unstructured":"Buckley, S. M. et al. Luciferin detection after intranasal vector delivery is improved by intranasal rather than intraperitoneal luciferin administration. Human gene therapy 19, 1050\u20131056 (2008).","journal-title":"Human gene therapy"},{"key":"1819_CR23","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.exger.2010.08.026","volume":"46","author":"C Benedict","year":"2011","unstructured":"Benedict, C. et al. Intranasal insulin as a therapeutic option in the treatment of cognitive impairments. Experimental gerontology 46, 112\u2013115 (2011).","journal-title":"Experimental gerontology"},{"key":"1819_CR24","doi-asserted-by":"publisher","first-page":"6734","DOI":"10.1523\/JNEUROSCI.1350-09.2009","volume":"29","author":"DR Marks","year":"2009","unstructured":"Marks, D. R., Tucker, K., Cavallin, M. A., Mast, T. G. & Fadool, D. A. Awake intranasal insulin delivery modifies protein complexes and alters memory, anxiety, and olfactory behaviors. The Journal of neuroscience 29, 6734\u20136751 (2009).","journal-title":"The Journal of neuroscience"},{"key":"1819_CR25","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1007\/s13346-011-0050-2","volume":"2","author":"LR Hanson","year":"2012","unstructured":"Hanson, L. R. et al. Intranasal delivery of deferoxamine reduces spatial memory loss in APP\/PS1 mice. Drug delivery and translational research 2, 160\u2013168 (2012).","journal-title":"Drug delivery and translational research"},{"key":"1819_CR26","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1089\/rej.2009.0944","volume":"13","author":"L Danielyan","year":"2010","unstructured":"Danielyan, L. et al. Protective effects of intranasal losartan in the APP\/PS1 transgenic mouse model of Alzheimer disease. Rejuvenation research 13, 195\u2013201 (2010).","journal-title":"Rejuvenation research"},{"key":"1819_CR27","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1089\/ars.2013.5371","volume":"20","author":"KR Parzych","year":"2014","unstructured":"Parzych, K. R. & Klionsky, D. J. An overview of autophagy: morphology, mechanism, and regulation. Antioxidants & redox signaling 20, 460\u2013473 (2014).","journal-title":"Antioxidants & redox signaling"},{"key":"1819_CR28","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1128\/JVI.02022-14","volume":"89","author":"N El-Hage","year":"2015","unstructured":"El-Hage, N. et al. HIV-1 and morphine regulation of autophagy in microglia: limited interactions in the context of HIV-1 infection and opioid abuse. Journal of virology 89, 1024\u20131035 (2015).","journal-title":"Journal of virology"},{"key":"1819_CR29","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1021\/mp400541z","volume":"11","author":"S Sajeesh","year":"2014","unstructured":"Sajeesh, S. et al. Long dsRNA-mediated RNA interference and immunostimulation: a targeted delivery approach using polyethyleneimine based nano-carriers. Molecular pharmaceutics 11, 872\u2013884 (2014).","journal-title":"Molecular pharmaceutics"},{"key":"1819_CR30","doi-asserted-by":"publisher","first-page":"10716","DOI":"10.1523\/JNEUROSCI.1398-04.2004","volume":"24","author":"P Jouvert","year":"2004","unstructured":"Jouvert, P. et al. Activation of the cGMP pathway in dopaminergic structures reduces cocaine-induced EGR-1 expression and locomotor activity. The Journal of neuroscience 24, 10716\u201310725 (2004).","journal-title":"The Journal of neuroscience"},{"key":"1819_CR31","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/j.bbrc.2012.03.155","volume":"421","author":"Y Liang","year":"2012","unstructured":"Liang, Y. et al. Delivery of cationic polymer-siRNA nanoparticles for gene therapies in neural regeneration. Biochemical and biophysical research communications 421, 690\u2013695 (2012).","journal-title":"Biochemical and biophysical research communications"},{"key":"1819_CR32","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1097\/01.MLG.0000199741.08517.99","volume":"116","author":"PG Djupesland","year":"2006","unstructured":"Djupesland, P. G., Skretting, A., Winderen, M. & Holand, T. Breath actuated device improves delivery to target sites beyond the nasal valve. The Laryngoscope 116, 466\u2013472 (2006).","journal-title":"The Laryngoscope"},{"key":"1819_CR33","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1021\/bm015640o","volume":"3","author":"S Sanchez-Cortes","year":"2002","unstructured":"Sanchez-Cortes, S., Berenguel, R. M., Madejon, A. & Perez-Mendez, M. Adsorption of polyethyleneimine on silver nanoparticles and its interaction with a plasmid DNA: a surface-enhanced Raman scattering study. Biomacromolecules 3, 655\u2013660 (2002).","journal-title":"Biomacromolecules"},{"key":"1819_CR34","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1021\/ac00217a012","volume":"62","author":"F Ni","year":"1990","unstructured":"Ni, F., Sheng, R. S. & Cotton, T. M. Flow injection analysis and real-time detection of RNA bases by surface-enhanced Raman spectroscopy. Analytical chemistry 62, 1958\u20131963 (1990).","journal-title":"Analytical chemistry"},{"key":"1819_CR35","doi-asserted-by":"publisher","first-page":"310","DOI":"10.3103\/S1068335614110025","volume":"41","author":"VS Gorelik","year":"2014","unstructured":"Gorelik, V. S., Krylov, A. S. & Sverbil, V. P. Local Raman spectroscopy of DNA. Bulletin of the Lebedev Physics Institute 41, 310\u2013315 (2014).","journal-title":"Bulletin of the Lebedev Physics Institute"},{"key":"1819_CR36","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1002\/ana.410320304","volume":"32","author":"E Masliah","year":"1992","unstructured":"Masliah, E. et al. Spectrum of human immunodeficiency virus-associated neocortical damage. Annals of neurology 32, 321\u2013329 (1992).","journal-title":"Annals of neurology"},{"key":"1819_CR37","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.1212\/WNL.43.11.2230","volume":"43","author":"JD Glass","year":"1993","unstructured":"Glass, J. D., Wesselingh, S. L., Selnes, O. A. & McArthur, J. C. Clinical-neuropathologic correlation in HIV-associated dementia. Neurology 43, 2230\u20132237 (1993).","journal-title":"Neurology"},{"key":"1819_CR38","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1159\/000150539","volume":"40","author":"JR Berger","year":"1997","unstructured":"Berger, J. R. & Nath, A. HIV dementia and the basal ganglia. Intervirology 40, 122\u2013131 (1997).","journal-title":"Intervirology"},{"key":"1819_CR39","doi-asserted-by":"publisher","first-page":"17","DOI":"10.2165\/00063030-200721010-00003","volume":"21","author":"Y Bennasser","year":"2007","unstructured":"Bennasser, Y., Yeung, M. L. & Jeang, K. T. RNAi therapy for HIV infection: principles and practicalities. BioDrugs: clinical immunotherapeutics, biopharmaceuticals and gene therapy 21, 17\u201322 (2007).","journal-title":"BioDrugs: clinical immunotherapeutics, biopharmaceuticals and gene therapy"},{"key":"1819_CR40","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/sj.gt.3302661","volume":"13","author":"JJ Rossi","year":"2006","unstructured":"Rossi, J. J. RNAi therapeutics: SNALPing siRNAs in vivo. Gene therapy 13, 583\u2013584 (2006).","journal-title":"Gene therapy"},{"key":"1819_CR41","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.cell.2008.06.034","volume":"134","author":"P Kumar","year":"2008","unstructured":"Kumar, P. et al. T cell-specific siRNA delivery suppresses HIV-1 infection in humanized mice. Cell 134, 577\u2013586 (2008).","journal-title":"Cell"},{"key":"1819_CR42","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1038\/mt.2009.271","volume":"18","author":"SS Kim","year":"2010","unstructured":"Kim, S. S. et al. RNAi-mediated CCR5 silencing by LFA-1-targeted nanoparticles prevents HIV infection in BLT mice. Molecular therapy 18, 370\u2013376 (2010).","journal-title":"Molecular therapy"},{"key":"1819_CR43","doi-asserted-by":"publisher","first-page":"66ra66","DOI":"10.1126\/scitranslmed.3001581","volume":"3","author":"CP Neff","year":"2011","unstructured":"Neff, C. P. et al. An aptamer-siRNA chimera suppresses HIV-1 viral loads and protects from helper CD4(+) T cell decline in humanized mice. Science translational medicine 3, 66ra66 (2011).","journal-title":"Science translational medicine"},{"key":"1819_CR44","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1038\/nm725","volume":"8","author":"CD Novina","year":"2002","unstructured":"Novina, C. D. et al. siRNA-directed inhibition of HIV-1 infection. Nature medicine 8, 681\u2013686 (2002).","journal-title":"Nature medicine"},{"key":"1819_CR45","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1182\/blood-2004-10-3959","volume":"106","author":"SK Lee","year":"2005","unstructured":"Lee, S. K. et al. Lentiviral delivery of short hairpin RNAs protects CD4 T cells from multiple clades and primary isolates of HIV. Blood 106, 818\u2013826 (2005).","journal-title":"Blood"},{"key":"1819_CR46","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1023\/A:1011958726518","volume":"16","author":"RL Juliano","year":"1999","unstructured":"Juliano, R. L., Alahari, S., Yoo, H., Kole, R. & Cho, M. Antisense pharmacodynamics: critical issues in the transport and delivery of antisense oligonucleotides. Pharmaceutical research 16, 494\u2013502 (1999).","journal-title":"Pharmaceutical research"},{"key":"1819_CR47","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1002\/jgm.1006","volume":"9","author":"AL Cardoso","year":"2007","unstructured":"Cardoso, A. L. et al. siRNA delivery by a transferrin-associated lipid-based vector: a non-viral strategy to mediate gene silencing. The journal of gene medicine 9, 170\u2013183 (2007).","journal-title":"The journal of gene medicine"},{"key":"1819_CR48","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1083\/jcb.200903070","volume":"186","author":"GB Kyei","year":"2009","unstructured":"Kyei, G. B. et al. Autophagy pathway intersects with HIV-1 biosynthesis and regulates viral yields in macrophages. The Journal of cell biology 186, 255\u2013268 (2009).","journal-title":"The Journal of cell biology"},{"key":"1819_CR49","doi-asserted-by":"publisher","first-page":"e5787","DOI":"10.1371\/journal.pone.0005787","volume":"4","author":"L Espert","year":"2009","unstructured":"Espert, L. et al. Differential role of autophagy in CD4 T cells and macrophages during X4 and R5 HIV-1 infection. PloS one 4, e5787 (2009).","journal-title":"PloS one"},{"key":"1819_CR50","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/icb.2014.88","volume":"93","author":"C Dinkins","year":"2015","unstructured":"Dinkins, C., Pilli, M. & Kehrl, J. H. Roles of autophagy in HIV infection. Immunology and cell biology 93, 11\u201317 (2015).","journal-title":"Immunology and cell biology"},{"key":"1819_CR51","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1084\/jem.20150956","volume":"212","author":"DC Rubinsztein","year":"2015","unstructured":"Rubinsztein, D. C., Bento, C. F. & Deretic, V. Therapeutic targeting of autophagy in neurodegenerative and infectious diseases. The Journal of experimental medicine 212, 979\u2013990 (2015).","journal-title":"The Journal of experimental medicine"},{"key":"1819_CR52","doi-asserted-by":"publisher","first-page":"6926","DOI":"10.1523\/JNEUROSCI.0800-08.2008","volume":"28","author":"B Boland","year":"2008","unstructured":"Boland, B. et al. Autophagy induction and autophagosome clearance in neurons: relationship to autophagic pathology in Alzheimer\u2019s disease. The Journal of neuroscience 28, 6926\u20136937 (2008).","journal-title":"The Journal of neuroscience"},{"key":"1819_CR53","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1111\/j.1750-3639.2011.00545.x","volume":"22","author":"CL Kragh","year":"2012","unstructured":"Kragh, C. L., Ubhi, K., Wyss-Coray, T. & Masliah, E. Autophagy in dementias. Brain pathology (Zurich, Switzerland) 22, 99\u2013109 (2012).","journal-title":"Brain pathology (Zurich, Switzerland)"},{"key":"1819_CR54","doi-asserted-by":"publisher","first-page":"628978","DOI":"10.1155\/2012\/628978","volume":"2012","author":"Y Tanaka","year":"2012","unstructured":"Tanaka, Y. et al. Autophagy as a therapeutic target in diabetic nephropathy. Experimental diabetes research 2012, 628978 (2012).","journal-title":"Experimental diabetes research"},{"key":"1819_CR55","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/nrneurol.2011.200","volume":"8","author":"H Harris","year":"2011","unstructured":"Harris, H. & Rubinsztein, D. C. Control of autophagy as a therapy for neurodegenerative disease. Nature reviews. Neurology 8, 108\u2013117 (2011).","journal-title":"Nature reviews. Neurology"},{"key":"1819_CR56","doi-asserted-by":"crossref","first-page":"34","DOI":"10.2533\/chimia.1997.34","volume":"51","author":"J-P Behr","year":"1997","unstructured":"Behr, J.-P. The Proton Sponge: a Trick to Enter Cells the Viruses Did Not Exploit. CHIMIA International Journal for Chemistry 51, 34\u201336 (1997).","journal-title":"CHIMIA International Journal for Chemistry"},{"key":"1819_CR57","doi-asserted-by":"publisher","first-page":"12530","DOI":"10.1073\/pnas.0804273106","volume":"106","author":"DS Markovic","year":"2009","unstructured":"Markovic, D. S. et al. Gliomas induce and exploit microglial MT1-MMP expression for tumor expansion. Proceedings of the National Academy of Sciences of the United States of America 106, 12530\u201312535 (2009).","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"1819_CR58","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.ejps.2015.11.009","volume":"82","author":"S Liu","year":"2016","unstructured":"Liu, S. et al. Inhibition of murine breast cancer growth and metastasis by survivin-targeted siRNA using disulfide cross-linked linear PEI. European journal of pharmaceutical sciences 82, 171\u2013182 (2016).","journal-title":"European journal of pharmaceutical sciences"},{"key":"1819_CR59","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3233\/JAD-1998-1102","volume":"1","author":"XQ Chen","year":"1998","unstructured":"Chen, X. Q., Fawcett, J. R., Rahman, Y. E., Ala, T. A. & Frey, I. W. Delivery of Nerve Growth Factor to the Brain via the Olfactory Pathway. Journal of Alzheimer\u2019s disease 1, 35\u201344 (1998).","journal-title":"Journal of Alzheimer\u2019s disease"},{"key":"1819_CR60","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/j.addr.2011.11.002","volume":"64","author":"JJ Lochhead","year":"2012","unstructured":"Lochhead, J. J. & Thorne, R. G. Intranasal delivery of biologics to the central nervous system. Advanced drug delivery reviews 64, 614\u2013628 (2012).","journal-title":"Advanced drug delivery reviews"},{"key":"1819_CR61","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S0022-3565(24)39336-X","volume":"293","author":"I Gozes","year":"2000","unstructured":"Gozes, I., Giladi, E., Pinhasov, A., Bardea, A. & Brenneman, D. E. Activity-dependent neurotrophic factor: intranasal administration of femtomolar-acting peptides improve performance in a water maze. The Journal of pharmacology and experimental therapeutics 293, 1091\u20131098 (2000).","journal-title":"The Journal of pharmacology and experimental therapeutics"},{"key":"1819_CR62","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1385\/JMN\/31:02:165","volume":"31","author":"Y Matsuoka","year":"2007","unstructured":"Matsuoka, Y. et al. Intranasal NAP administration reduces accumulation of amyloid peptide and tau hyperphosphorylation in a transgenic mouse model of Alzheimer\u2019s disease at early pathological stage. Journal of molecular neuroscience 31, 165\u2013170 (2007).","journal-title":"Journal of molecular neuroscience"},{"key":"1819_CR63","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1038\/nn0602-849","volume":"5","author":"J Born","year":"2002","unstructured":"Born, J. et al. Sniffing neuropeptides: a transnasal approach to the human brain. Nature neuroscience 5, 514\u2013516 (2002).","journal-title":"Nature neuroscience"},{"key":"1819_CR64","first-page":"1144","volume":"86","author":"HL Fehm","year":"2001","unstructured":"Fehm, H. L. et al. The melanocortin melanocyte-stimulating hormone\/adrenocorticotropin(4-10) decreases body fat in humans. The Journal of clinical endocrinology and metabolism 86, 1144\u20131148 (2001).","journal-title":"The Journal of clinical endocrinology and metabolism"},{"key":"1819_CR65","doi-asserted-by":"publisher","first-page":"195","DOI":"10.3109\/10717549709051892","volume":"4","author":"P Sigurdsson","year":"1997","unstructured":"Sigurdsson, P., Thorvaldsson, T., Gizurarson, S. & Gunnarsson, E. Olfactory Absorption of Insulin to the Brain. Drug Delivery 4, 195\u2013200 (1997).","journal-title":"Drug Delivery"},{"key":"1819_CR66","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1212\/01.WNL.0000265401.62434.36","volume":"70","author":"MA Reger","year":"2008","unstructured":"Reger, M. A. et al. Intranasal insulin improves cognition and modulates beta-amyloid in early AD. Neurology 70, 440\u2013448 (2008).","journal-title":"Neurology"},{"key":"1819_CR67","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1093\/scan\/nss062","volume":"8","author":"S Leknes","year":"2013","unstructured":"Leknes, S. et al. Oxytocin enhances pupil dilation and sensitivity to \u2018hidden\u2019 emotional expressions. Social cognitive and affective neuroscience 8, 741\u2013749 (2013).","journal-title":"Social cognitive and affective neuroscience"},{"key":"1819_CR68","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1002\/mds.26351","volume":"30","author":"LK Mischley","year":"2015","unstructured":"Mischley, L. K. et al. A randomized, double-blind phase I\/IIa study of intranasal glutathione in Parkinson\u2019s disease. Movement disorders 30, 1696\u20131701 (2015).","journal-title":"Movement disorders"},{"key":"1819_CR69","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1136\/jmg.2008.062141","volume":"46","author":"H Schmidt","year":"2009","unstructured":"Schmidt, H., Kern, W., Giese, R., Hallschmid, M. & Enders, A. Intranasal insulin to improve developmental delay in children with 22q13 deletion syndrome: an exploratory clinical trial. Journal of medical genetics 46, 217\u2013222 (2009).","journal-title":"Journal of medical genetics"},{"key":"1819_CR70","doi-asserted-by":"publisher","first-page":"557","DOI":"10.2337\/diabetes.48.3.557","volume":"48","author":"W Kern","year":"1999","unstructured":"Kern, W., Born, J., Schreiber, H. & Fehm, H. L. Central nervous system effects of intranasally administered insulin during euglycemia in men. Diabetes 48, 557\u2013563 (1999).","journal-title":"Diabetes"},{"key":"1819_CR71","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1016\/j.psyneuen.2004.04.003","volume":"29","author":"C Benedict","year":"2004","unstructured":"Benedict, C. et al. Intranasal insulin improves memory in humans. Psychoneuroendocrinology 29, 1326\u20131334 (2004).","journal-title":"Psychoneuroendocrinology"},{"key":"1819_CR72","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1210\/jc.2007-2606","volume":"93","author":"C Benedict","year":"2008","unstructured":"Benedict, C., Kern, W., Schultes, B., Born, J. & Hallschmid, M. Differential sensitivity of men and women to anorexigenic and memory-improving effects of intranasal insulin. The Journal of clinical endocrinology and metabolism 93, 1339\u20131344 (2008).","journal-title":"The Journal of clinical endocrinology and metabolism"},{"key":"1819_CR73","doi-asserted-by":"publisher","first-page":"114","DOI":"10.2337\/db10-0329","volume":"60","author":"C Benedict","year":"2011","unstructured":"Benedict, C. et al. Intranasal insulin enhances postprandial thermogenesis and lowers postprandial serum insulin levels in healthy men. Diabetes 60, 114\u2013118 (2011).","journal-title":"Diabetes"},{"key":"1819_CR74","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1016\/S0006-3223(03)00465-7","volume":"54","author":"M Heinrichs","year":"2003","unstructured":"Heinrichs, M., Baumgartner, T., Kirschbaum, C. & Ehlert, U. Social support and oxytocin interact to suppress cortisol and subjective responses to psychosocial stress. Biological psychiatry 54, 1389\u20131398 (2003).","journal-title":"Biological psychiatry"},{"key":"1819_CR75","doi-asserted-by":"publisher","first-page":"11489","DOI":"10.1523\/JNEUROSCI.3984-05.2005","volume":"25","author":"P Kirsch","year":"2005","unstructured":"Kirsch, P. et al. Oxytocin modulates neural circuitry for social cognition and fear in humans. The Journal of neuroscience 25, 11489\u201311493 (2005).","journal-title":"The Journal of neuroscience"},{"issue":"Suppl","key":"1819_CR76","doi-asserted-by":"publisher","first-page":"S58","DOI":"10.1002\/ana.410230716","volume":"23","author":"C Cheng-Mayer","year":"1988","unstructured":"Cheng-Mayer, C. & Levy, J. A. Distinct biological and serological properties of human immunodeficiency viruses from the brain. Annals of neurology 23(Suppl), S58\u201361 (1988).","journal-title":"Annals of neurology"},{"key":"1819_CR77","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1097\/QAD.0b013e3283639804","volume":"27","author":"N El-Hage","year":"2013","unstructured":"El-Hage, N. et al. A novel bivalent HIV-1 entry inhibitor reveals fundamental differences in CCR5-mu-opioid receptor interactions between human astroglia and microglia. AIDS (London, England) 27, 2181\u20132190 (2013).","journal-title":"AIDS (London, England)"},{"key":"1819_CR78","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1097\/QAD.0000000000000291","volume":"28","author":"N El-Hage","year":"2014","unstructured":"El-Hage, N. et al. Ibudilast (AV411), and its AV1013 analog, reduce HIV-1 replication and neuronal death induced by HIV-1 and morphine. AIDS (London, England) 28, 1409\u20131419 (2014).","journal-title":"AIDS (London, England)"}],"updated-by":[{"DOI":"10.1038\/s41598-018-23078-y","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2018,3,14]],"date-time":"2018-03-14T00:00:00Z","timestamp":1520985600000}}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-01819-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-01819-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-01819-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T08:37:05Z","timestamp":1750235825000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-01819-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,12]]},"references-count":78,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["1819"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-01819-9","relation":{"correction":[{"id-type":"doi","id":"10.1038\/s41598-018-23078-y","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,12]]},"assertion":[{"value":"22 January 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2018","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A correction to this article has been published and is linked from the HTML and PDF versions of this paper. The error has not been fixed in the paper.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"1862"}}